Literature DB >> 11342005

The measured level of prion infectivity varies in a predictable way according to the aggregation state of the infectious agent.

J Masel1, V A Jansen.   

Abstract

Transmissible spongiform encephalopathies are believed to be caused by an infectious form of the prion protein, designated PrP(Sc). The concentration of PrP(Sc) is often poorly correlated to the level of infectivity. Infectivity can be measured in two ways, namely endpoint titration and the incubation time assay, but patterns of infectivity vary depending on which method is used. These discrepancies can be explained by variation in the aggregation state of PrP(Sc). Both methods of measuring infectivity are modelled mathematically, and the theoretical results are in agreement with published data. It was found to be theoretically impossible to characterise prion infectivity by a multiple of a single quantity representing 'one prion', no matter how it is measured. Infectivity is instead characterised by both the number and sizes of the PrP(Sc) aggregates. Apparent discrepancies arise when these complexities are reduced to a single number.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342005     DOI: 10.1016/s0925-4439(00)00095-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Kinetics of prion growth.

Authors:  Thorsten Pöschel; Nikolai V Brilliantov; Cornelius Frömmel
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

Review 2.  Prion propagation: the role of protein dynamics.

Authors:  John A Pezza; Tricia R Serio
Journal:  Prion       Date:  2007-01-10       Impact factor: 3.931

3.  Cell-free formation of misfolded prion protein with authentic prion infectivity.

Authors:  Petra Weber; Armin Giese; Niklas Piening; Gerda Mitteregger; Achim Thomzig; Michael Beekes; Hans A Kretzschmar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

4.  Quantifying BSE control by calculating the basic reproduction ratio R0 for the infection among cattle.

Authors:  Aline de Koeijer; Hans Heesterbeek; Bram Schreuder; Radulf Oberthür; John Wilesmith; Herman van Roermund; Mart de Jong
Journal:  J Math Biol       Date:  2003-06-12       Impact factor: 2.259

5.  PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP.

Authors:  Gustavo Sajnani; Christopher J Silva; Adriana Ramos; Miguel A Pastrana; Bruce C Onisko; Melissa L Erickson; Elizabeth M Antaki; Irina Dynin; Ester Vázquez-Fernández; Christina J Sigurdson; J Mark Carter; Jesús R Requena
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

6.  Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast.

Authors:  Janice Villali; Jason Dark; Teal M Brechtel; Fen Pei; Suzanne S Sindi; Tricia R Serio
Journal:  Nat Struct Mol Biol       Date:  2020-05-04       Impact factor: 15.369

7.  Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue.

Authors:  Lauren V C Miller; Aamir S Mukadam; Claire S Durrant; Marina J Vaysburd; Taxiarchis Katsinelos; Benjamin J Tuck; Sophie Sanford; Olivia Sheppard; Claire Knox; Shi Cheng; Leo C James; Michael P Coleman; William A McEwan
Journal:  Acta Neuropathol Commun       Date:  2021-03-12       Impact factor: 7.801

8.  Ultraviolet-ozone treatment reduces levels of disease-associated prion protein and prion infectivity.

Authors:  Christopher J Johnson; P U P A Gilbert; Debbie McKenzie; Joel A Pedersen; Judd M Aiken
Journal:  BMC Res Notes       Date:  2009-07-06

Review 9.  [PIN+]ing down the mechanism of prion appearance.

Authors:  Tricia R Serio
Journal:  FEMS Yeast Res       Date:  2018-05-01       Impact factor: 2.796

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.